Halozyme Therapeutics HALO
NASDAQ HALO
$109.86 +2.92 (+2.73%)
At close: Oct 2, 2026 · 4:00 PM EDT

Halozyme Therapeutics (HALO) Return on Assets [ROA] (2011 - 2026)

Updated

Halozyme Therapeutics (HALO) posted Return on Assets [ROA] of 15.75% for Q2 2026, down 10.47 percentage points from 26.22% a year earlier but up 2.33 percentage points from the prior quarter.

Analysis

Halozyme Therapeutics (HALO) Return on Assets [ROA] (2011 - 2026) Analysis & Trends

For FY2025, Halozyme Therapeutics' Return on Assets [ROA] came in at 13.81%, down 9.58 percentage points from FY2024.

  • Annual Return on Assets [ROA] shows a five-year change of -8.72 percentage points (FY2020 to FY2025).
  • In prior years, Halozyme Therapeutics' Return on Assets [ROA] was 23.39% in FY2024 (+7.64 pp), 15.75% in FY2023 (+2.03 pp), 13.72% in FY2022 (-34.10 pp) and 47.82% in FY2021 (+25.29 pp).
  • Quarterly Return on Assets [ROA] has run from a low of 10.26% in Q1 2023 to a high of 38.38% in Q1 2022 over five years.
  • On a year-over-year basis, Return on Assets [ROA] has declined in each of the last three quarters, with an average year-over-year change of +0.70 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q3 2021, with a gain of 32.91 percentage points; the weakest was Q1 2023, with a drop of 28.12 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was 13.42% (Q1 2026), 13.35% (Q4 2025) and 27.86% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Halozyme Therapeutics 12.53 Bn 11.13 Bn 401.83 Mn 15.75%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.75%
Mar 31, 2026 13.42%
Dec 31, 2025 13.35%
Sep 30, 2025 27.86%
Jun 30, 2025 26.22%
Mar 31, 2025 22.79%
Dec 31, 2024 21.24%
Sep 30, 2024 19.20%
Jun 30, 2024 17.70%
Mar 31, 2024 17.84%
Dec 31, 2023 15.53%
Sep 30, 2023 13.71%
Jun 30, 2023 13.32%
Mar 31, 2023 10.26%
Dec 31, 2022 10.91%
Sep 30, 2022 11.59%
Jun 30, 2022 24.88%
Mar 31, 2022 38.38%
Dec 31, 2021 35.17%
Sep 30, 2021 37.00%
API Access

Halozyme Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=HALO&period=max&api_key=YOUR_API_KEY